Guardant Health
GH
#1571
Rank
โ‚น1.196 T
Marketcap
โ‚น9,212
Share price
0.68%
Change (1 day)
210.77%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -โ‚น277.33

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น289.71. In 2024 the company made an earnings per share (EPS) of -โ‚น321.30 an increase over its 2023 EPS that were of -โ‚น386.28.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น277.33-13.68%
2024-โ‚น321.30-16.82%
2023-โ‚น386.28-33.13%
2022-โ‚น577.6260%
2021-โ‚น361.0155.04%
2020-โ‚น232.85207.14%
2019-โ‚น75.81-19.81%
2018-โ‚น94.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
-โ‚น193.14-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-โ‚น433.85 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA